CA2399873A1 - Drug metabolizing enzymes - Google Patents

Drug metabolizing enzymes Download PDF

Info

Publication number
CA2399873A1
CA2399873A1 CA002399873A CA2399873A CA2399873A1 CA 2399873 A1 CA2399873 A1 CA 2399873A1 CA 002399873 A CA002399873 A CA 002399873A CA 2399873 A CA2399873 A CA 2399873A CA 2399873 A1 CA2399873 A1 CA 2399873A1
Authority
CA
Canada
Prior art keywords
polynucleotide
polypeptide
dme
sequence
sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002399873A
Other languages
English (en)
French (fr)
Inventor
Y. Tom Tang
Henry Yue
Mariah R. Baughn
Monique G. Yao
Olga Bandman
Yalda Azimzai
Preeti Lal
Ameena R. Gandhi
Huijun Z. Ring
Leo L. Shih
Junming Yang
Jennifer L. Policky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2399873A1 publication Critical patent/CA2399873A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA002399873A 2000-02-11 2001-02-08 Drug metabolizing enzymes Abandoned CA2399873A1 (en)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US18185600P 2000-02-11 2000-02-11
US60/181,856 2000-02-11
US18368400P 2000-02-17 2000-02-17
US60/183,684 2000-02-17
US18514100P 2000-02-25 2000-02-25
US60/185,141 2000-02-25
US18681800P 2000-03-03 2000-03-03
US60/186,818 2000-03-03
US18834500P 2000-03-09 2000-03-09
US60/188,345 2000-03-09
US18999700P 2000-03-17 2000-03-17
US60/189,997 2000-03-17
PCT/US2001/004423 WO2001059127A2 (en) 2000-02-11 2001-02-08 Drug metabolizing enzymes

Publications (1)

Publication Number Publication Date
CA2399873A1 true CA2399873A1 (en) 2001-08-16

Family

ID=27558717

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002399873A Abandoned CA2399873A1 (en) 2000-02-11 2001-02-08 Drug metabolizing enzymes

Country Status (5)

Country Link
EP (1) EP1254236A2 (ja)
JP (1) JP2003522528A (ja)
AU (1) AU2001235000A1 (ja)
CA (1) CA2399873A1 (ja)
WO (1) WO2001059127A2 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137890A1 (en) 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1328151A4 (en) * 1999-04-29 2004-06-16 Univ Tennessee Res Corp ISOLATED P-HYDE FAMILY NUCLEIC ACIDS, P-HYDE PROTEINS AND METHOD FOR INDUCING SUSCEPTIBILITY TO INDUCED PROGRAMMED CELL DEATH DURING CANCER
US6835812B1 (en) 1999-04-29 2004-12-28 University Of Tennessee Research Corporation Human p-Hyde proteins
US20020022254A1 (en) * 2000-07-28 2002-02-21 Karl Guegler Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
US20030148920A1 (en) * 2000-12-27 2003-08-07 Steven Rosen Sulfatases and methods of use thereof
US20060063230A1 (en) 2000-12-27 2006-03-23 Roman Naworth Sulfatases and methods of use thereof
GB0202748D0 (en) * 2002-02-06 2002-03-27 Impharmatica Ltd Protein

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0463395B1 (en) * 1990-06-22 1997-05-14 F. Hoffmann-La Roche Ag Detection of poor metabolizers of drugs
GB9225845D0 (en) * 1992-12-10 1993-02-03 Nickerson Biocem Ltd Modified plants
US6136964A (en) * 1996-03-19 2000-10-24 Cell Therapeutics, Inc. Mammalian lysophosphatidic acid acyltransferase
AU7600098A (en) * 1997-05-27 1998-12-30 Icos Corporation Novel lysophosphatidic acid acyltransferase
US5888793A (en) * 1998-02-25 1999-03-30 Incyte Pharmaceuticals, Inc. Human lysophosphatidic acid acyltransferase

Also Published As

Publication number Publication date
EP1254236A2 (en) 2002-11-06
WO2001059127A2 (en) 2001-08-16
JP2003522528A (ja) 2003-07-29
WO2001059127A3 (en) 2002-02-07
AU2001235000A1 (en) 2001-08-20

Similar Documents

Publication Publication Date Title
EP1254235A2 (en) Drug metabolizing enzymes
US20040029132A1 (en) Drug metabolizing enzymes
US20040253588A1 (en) Drug metabolizing enzymes
US20040110259A1 (en) Drug metabolizing enzymes
CA2399873A1 (en) Drug metabolizing enzymes
CA2403644A1 (en) Drug metabolizing enzymes
EP1370662A2 (en) Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor
US20050181415A1 (en) Drug metabolizing enzymes
CA2417769A1 (en) Drug metabolizing enzymes
US20040029125A1 (en) Drug metabolizing enzymes
US20040081980A1 (en) Drug metabolizing enzymes
WO2002066654A2 (en) Drug metabolizing enzymes
US20040082061A1 (en) Drug metabolizing enzymes
US20030138895A1 (en) Drug metabolizing enzymes
US20040086887A1 (en) Drug metabolizing enzymes
EP1572877A2 (en) Drug metabolizing enzymes
WO2002026988A2 (en) Human drug metabolizing enzymes
WO2002090521A2 (en) Drug metabolizing enzymes

Legal Events

Date Code Title Description
FZDE Dead